Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. Sep-Oct 2016;35(5):419-32.
doi: 10.1080/01459740.2016.1167055. Epub 2016 Mar 30.

Ambiguous Capture: Collaborative Capitalism and the Meningitis Vaccine Project

Affiliations
Free PMC article

Ambiguous Capture: Collaborative Capitalism and the Meningitis Vaccine Project

Janice Graham. Med Anthropol. .
Free PMC article

Abstract

The primary health care approach advanced at Alma Ata to address social determinants of health was replaced by selective health care a year later at Bellagio. Subsequently, immunization was endorsed as a cost-effective technical intervention to combat targeted infectious diseases. Multilateral efforts to collaborate on immunization as a universal public health good ambiguously capture the interests of the world's governments as well as private, public, and not-for-profit institutions. Global assemblages of scientists, governments, industry and nongovernmental organizations now work in public-private partnerships to develop and make essential vaccines accessible, with vaccines marketed as single fix solutions for global health. Drawing from ethnographic fieldwork in France and Burkina Faso that followed the development, regulation, and implementation of the group A meningococcal conjugate vaccine for sub-Saharan Africa, in this article I describe events during and after the development of MenAfriVac. A technological success narrative steeped in collaborative capitalist rhetoric disguises neglected health care systems.

Keywords: Burkina Faso; public-private partnership; regulatory capture; technology transfer; vaccine development.

Comment in

Similar articles

See all similar articles

Cited by 3 articles

References

    1. Abraham J. Science, politics and the pharmaceutical industry: Controversy and bias in drug regulation. London: UCL Press; 1995.
    1. Aguado M. T., Jodar L., Granoff D., Rabinovich R., Ceccarini C., Perkin G. W. From epidemic meningitis vaccines for Africa to the Meningitis Vaccine Project. Clinical Infectious Diseases. 2015;61(S5):S391–S395. - PMC - PubMed
    1. Atun R. A., Bennett S., Duran A. When do vertical (stand-alone) programmes have a place in health system? Denmark: WHO Regional Office for Europe and European Observatory and Health Systems and Policies; 2008. Copenhagen.
    1. Barr D. A research protocol to evaluate the effectiveness of public–private partnerships as a means to improve health and welfare systems worldwide. American Journal of Public Health. 2007;97(1):19–25. - PMC - PubMed
    1. Berlier M., Barry R., Shadid J., Sirica C., Brunier A., Hasan H., Bouma E. Communication challenges during the development and introduction of a new meningococcal vaccine in Africa. Clinical Infectious Diseases. 2015;61(S5):S451–S458. - PMC - PubMed

Publication types

MeSH terms

Feedback